Forecasts data is unavailable for this security.
- 1yr ago
- 3M ago
- 2M ago
- 1M ago
Select bar for recommendation details.
Reuters Investment Profile
Ford Investor Services, Inc.
Value Graph: CTI BIOPHARMA -- CTIC
1 page, 28 Oct 2016
S&P Capital IQ Quantitative Report
12 pages, 22 Oct 2016
CTI BioPharma Corp. (CTIC) - Financial and Strategic SWOT Analysis Review
93 pages, 06 Oct 2016
Share price forecast
The 2 analysts offering 12 month price targets for
CTI BioPharma Corp have a median target of 0.375, with a high estimate of 0.75 and a low estimate of 0.00. The median estimate represents a -23.97% decrease from the last price of 0.4932.
Earnings history & estimates
The next earnings announcement is expected on Feb 14, 2017.
|Average growth rate||-7.54%|
The next earnings announcement from
|Average growth rate||+19.02%|
Revenue history & estimates
|Average growth rate||+294.30%|
|Average growth rate||+807.69%|